Literature DB >> 8750012

Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor.

Y Chernajovsky1, G Adams, O L Podhajcer, G M Mueller, P D Robbins, M Feldmann.   

Abstract

Collagen-induced arthritis can be transferred into severe combined immunodeficiency (SCID) mice by spleen cells from diseased DBA/1 mice. The development of arthritis in SCID animals can be prevented by infection ex vivo of DBA/1 spleen cells with retroviruses expressing the monomeric soluble human p75 tumor necrosis factor (TNF) receptor (TNF-R). In addition, a vector engineered to express a polycystronic mRNA with TNF-R and the herpes simplex virus thymidine kinase (HSVtk) gene, while producing low levels of TNF-R, had a limited effect which could be blocked by treating the animals with ganciclovir. A retroviral vector expressing the HSVtk gene alone had no effect on this arthritis transfer model with or without ganciclovir. Serum levels of TNF-R did not correlate with clinical signs, however, lower anti-collagen antibody levels corresponded with lack of clinical symptoms. These results indicate that local production of cytokine inhibitor is essential for therapeutic purposes while systemic levels may not be required.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8750012

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  14 in total

Review 1.  Gene therapy works in animal models of rheumatoid arthritis...so what!

Authors:  Fons A J van de Loo; Jeroen Geurts; Wim B van den Berg
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 2.  Gene therapy for rheumatoid arthritis.

Authors:  P D Robbins; C H Evans; Y Chernajovsky
Journal:  Springer Semin Immunopathol       Date:  1998

3.  Gene therapy in autoimmune diseases.

Authors:  C H Evans; J D Whalen; C H Evans; S C Ghivizzani; P D Robbins
Journal:  Ann Rheum Dis       Date:  1998-03       Impact factor: 19.103

Review 4.  Gene therapy for rheumatoid arthritis. Theoretical considerations.

Authors:  Y Chernajovsky; A Annenkov; C Herman; K Triantaphyllopoulos; D Gould; H Dreja; S P Moyes; J L Croxford; R A Mageed; O L Podhajcer; D Baker
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 5.  Gene therapy for autoimmune disorders.

Authors:  C H Evans; S C Ghivizzani; T J Oligino; P D Robbins
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

Review 6.  A gene therapy approach to treatment of autoimmune disease.

Authors:  C M Seroogy; C G Fathman
Journal:  Immunol Res       Date:  1998-08       Impact factor: 2.829

Review 7.  Concepts in gene therapy for cartilage repair.

Authors:  Andre F Steinert; Ulrich Nöth; Rocky S Tuan
Journal:  Injury       Date:  2008-04       Impact factor: 2.586

Review 8.  Gene therapy for rheumatoid arthritis.

Authors:  E Gouze; S C Ghivizzani; P D Robbins; C H Evans
Journal:  Curr Rheumatol Rep       Date:  2001-02       Impact factor: 4.686

9.  Gene therapy for arthritis--where do we stand?

Authors:  Yuti Chernajovsky
Journal:  Arthritis Res Ther       Date:  2005-09-14       Impact factor: 5.156

Review 10.  Gene therapy for arthritis.

Authors:  Russell S Traister; Raphael Hirsch
Journal:  Mod Rheumatol       Date:  2008-01-05       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.